Default: Journal of Cancer

ISSN:

Journal Home

Journal Guideline

Journal of Cancer Q2 Unclaimed

Ivyspring International Publisher Australia
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Cancer is a journal indexed in SJR in Oncology with an H index of 81. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1220 €. The scope of the journal is focused on medicine, cancer, oncology, cancer pathology, hematology. It has an SJR impact factor of 0,901 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,901.

Journal of Cancer focuses its scope in these topics and keywords: cancer, expression, tumor, poor, erg, human, hypotheses, implications, growth, messageglutamate, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

DOAJ Scopus WOS
Categories: Oncology (Q2)
Price

1220 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Cancer

0,901

SJR Impact factor

81

H Index

293

Total Docs (Last Year)

1770

Total Docs (3 years)

13234

Total Refs

6288

Total Cites (3 years)

1767

Citable Docs (3 years)

3.32

Cites/Doc (2 years)

45.17

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, expression, tumor, poor, erg, human, hypotheses, implications, growth, messageglutamate, hypercalcemic, intercellular, lincmirpemt, lung, messenger, metastases, metastasis, microenvironmentoip, gene, foxp, breast, cancerthe, carcinoma, carcinomaan, cell, cells, chemoresistance, cisplatin, clinical, decarboxylase, epithelialmesenchymal, exosomes, factor, findings, medicine, cancer, oncology, cancer pathology, hematology

FAQS